Electrophysiologic effects of milrinone in patients with congestive heart failure
- 1 May 1986
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 57 (8) , 624-628
- https://doi.org/10.1016/0002-9149(86)90847-7
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Factors influencing the one-year mortality of dilated cardiomyopathyThe American Journal of Cardiology, 1984
- Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1984
- High-performance liquid chromatographic analysis of milrinone in plasma and urine : Intravenous pharmacokinetics in the dogJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Antiarrhythmic Drugs: a Possible Cause of Out-of-Hospital Cardiac ArrestNew England Journal of Medicine, 1983
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Cardiotonic Activity of Milrinone, a New and Potent Cardiac Bipyridine, on the Normal and Failing Heart of Experimental AnimalsJournal of Cardiovascular Pharmacology, 1983
- Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activityJournal of the American College of Cardiology, 1983
- Characterization of the Cardiotonic Effects of Milrinone, a New and Potent Cardiac Bipyridine, on Isolated Tissues from Several Animal SpeciesJournal of Cardiovascular Pharmacology, 1983
- Long-term therapy with a new cardiotonic agent, WIN 47203: Drug-dependent improvement in cardiac performance and progression of the underlying diseaseJournal of the American College of Cardiology, 1983
- Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.Circulation, 1983